Skip to main content
. 2015 Jun 1;8(6):6434–6441.

Figure 2.

Figure 2

Formononetin enhanced doxorubicin sensitivity in glioma cells. Three glioma cell lines including U87MG (A), U251MG (B) and T98G (C) were incubated with doxorubicin alone or in combination with formononetin (100 μM) for 48 h. CCK-8 assay was performed to measure the cell viability of different glioma cell lines. *P < 0.05; **P < 0.01.